UiPath (PATH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The market for robotic process automation should expand dramatically. UiPath -- a key player in this cutting-edge field -- has felt some hiccups lately.
PATH has faced near-term challenges, but shows promise due to its growing customer base, healthy balance sheet, and recent share repurchase authorization. Despite the mixed earnings and decelerating ARR growth, the raised FY2025 guidance and new AI product releases in Q3'24 offer potential for renewed growth opportunities. PATH's valuation remains attractive with a FWD PEG non-GAAP ratio of 1.16x, compared to its automation/AI SaaS peers.
The robotic process-automation industry that UiPath pioneered is growing rapidly. UiPath has been losing market share to C3.ai and Microsoft.
UiPath reported solid Q2 results following its disastrous Q1 report. The company is seeing strong renewal rates and net dollar retention.
UiPath Inc. (NYSE:PATH ) Piper Sandler Growth Frontiers Conference September 10, 2024 10:30 AM ET Company Participants Ashim Gupta - Chief Financial Officer Conference Call Participants Unidentified Company Representative Right. Well, we've reached the bottom of the hour, so I think we're ready to go.
UiPath is launching innovative products to help companies automate repetitive tasks.
UiPath took a step forward by increasing its profit outlook for the rest of its fiscal year.
Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
UiPath NYSE: PATH share price issues are behind it now that the Q2 results are in. The pullback shaved more than 50% off of the stock price as expectations were reset, setting up the opportunity today.
UiPath's growth slowed due to AI integration, but RPA demand may accelerate; the founder returned as CEO to drive growth. Fiscal 2Q25 results showed 10% revenue growth, declining margins, and flat cash flow; AI and RPA confusion is dissipating. Stock valuation reset from 45x to 25x cash earnings; potential 63% upside if top-line growth hits 15% for 2026.
UiPath beat estimates in the second quarter, but growth is slowing. The company remains deeply unprofitable on a GAAP basis.